共 266 条
[1]
Kim JH(2021)Trends of age-related non-communicable diseases in people living with HIV and comparison with uninfected controls: a nationwide population-based study in South Korea HIV Med 22 824-833
[2]
Noh J(2022)Osteoporosis and HIV infection Calcif Tissue Int 110 624-640
[3]
Kim W(2010)HIV and bone disease Arch Biochem Biophys 503 66-77
[4]
Seong H(2020)Management of osteoporosis in patients living with HIV-A systematic review and meta-analysis J Acquir Immune Defic Syndr 83 1-8
[5]
Kim JH(2020)Bone mineral density changes among people living with HIV who have started with TDF-containing regimen: a five-year prospective study PLoS ONE 15 e0230368-485
[6]
Lee WJ(2018)Switch from tenofovir disoproxil fumarate combination to dolutegravir with rilpivirine improves parameters of bone health AIDS 32 477-765
[7]
Biver E(2008)Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women Cochrane Database Syst Rev 1 CD001155-431
[8]
Stone B(2009)Denosumab for prevention of fractures in postmenopausal women with osteoporosis N Engl J Med 361 756-345
[9]
Dockrell D(2005)Alendronate, vitamin D, and calcium for the treatment of osteopenia/osteoporosis associated with HIV infection J Acquir Immune Defic Syndr 38 426-88
[10]
Bowman C(2005)Reversal of HIV-1-associated osteoporosis with once-weekly alendronate AIDS 19 343-326